Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non–Small-Cell Lung Cancer
Titel:
Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non–Small-Cell Lung Cancer
Auteur:
Garon, Edward B. Reck, Martin Paz-Ares, Luis Ponce, Santiago Jaime, Jesus Corral Juan, Oscar Nadal, Ernest Lee, Pablo Dalal, Rita Liu, Jingyi He, Shuang Treat, Joseph Nakagawa, Kazuhiko